title: Poor penetration of the male genital tract by HIV-1 protease inhibitors.
authors.forename: S
authors.initials: S
authors.lastname: Taylor
authors.forename: D J
authors.initials: DJ
authors.lastname: Back
authors.forename: J
authors.initials: J
authors.lastname: Workman
authors.forename: S M
authors.initials: SM
authors.lastname: Drake
authors.forename: D J
authors.initials: DJ
authors.lastname: White
authors.forename: B
authors.initials: B
authors.lastname: Choudhury
authors.forename: P A
authors.initials: PA
authors.lastname: Cane
authors.forename: G M
authors.initials: GM
authors.lastname: Beards
authors.forename: K
authors.initials: K
authors.lastname: Halifax
authors.forename: D
authors.initials: D
authors.lastname: Pillay
mesh_terms: D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019258:Saquinavir / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012661:Semen / Q000378:metabolism*; D018119:Stavudine / Q000627:therapeutic use
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine; D019258:Saquinavir; D019438:Ritonavir